Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 1 Study of Mosliciguat in Healthy, Adult Males
Sponsor: Pulmovant, Inc.
Summary
This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.
Official title: An Open-Label, Phase 1 Study to Investigate the Absolute Bioavailability and the Absorption, Metabolism, and Excretion of [14C]-Mosliciguat in Healthy, Adult Males
Key Details
Gender
MALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2025-06-10
Completion Date
2026-05
Last Updated
2025-09-22
Healthy Volunteers
Yes
Conditions
Interventions
Mosliciguat
Dose level for inhalation
14C mosliciguat
Dose level
Dry Powder Inhaler
Dry powder inhaler for mosliciguat
Locations (1)
Pharmaron
Baltimore, Maryland, United States